Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • daughart
    Junior Member
    • Aug 2010
    • 5

    #1

    Comparing Poly(A)+ selection methods - rRNA contamination, yield, etc.

    My previous RNA-seq experience is with total RNA-seq, using RiboMinus to deplete rRNAs. Now we are considering mRNA-seq. We plan on using the Illumina dUTP paired-end library construction method with human RNA from whole blood (Leuko-lock). Our starting amount is 12-18 ug of total RNA, which is on the low end.

    What are your experiences with Poly(A)+ selection and RNA-seq?

    MicroPoly(A)Purist (considering our small starting amount) - do we need to do RiboMinus first, or two rounds of MicroPoly(A)Purist? What efficiency should we expect, both in amt. of recovered Poly(A)+ RNA and number of rRNA reads in the final sequencing?

    What about DynaBeads oligo(dT) purification? Are there any other favorite methods? I would really appreciate any advice people can give, or if you can link to other posts. I've already gone through many of them, and there's a lot of mixed advice out there.
  • pmiguel
    Senior Member
    • Aug 2008
    • 2328

    #2
    We get 2-3x higher yields with the old style, non-magnetic, oligo dT cellulose (batch hybe + spin columns) than using magnetic beads. No idea why. (PolyA Purist is the kit we currently use.)

    That said there are enormous tissue/organism specific variation in polyA content of total RNA. So your best bet is to switch your research to working on fish gonads. polyA yields are crazy high!

    --
    Phillip

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...